Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Aleta L Svitak"'
Autor:
Jared M. Fine, Jacob Kosyakovsky, Amanda M. Baillargeon, Julian V. Tokarev, Jacob M. Cooner, Aleta L. Svitak, Katherine A. Faltesek, William H. Frey II, Leah R. Hanson
Publikováno v:
Brain and Behavior, Vol 10, Iss 3, Pp n/a-n/a (2020)
Abstract Introduction Intranasal deferoxamine (IN DFO) has been shown to decrease memory loss and have beneficial impacts across several models of neurologic disease and injury, including rodent models of Alzheimer's and Parkinson's disease. Methods
Externí odkaz:
https://doaj.org/article/ddb5a9d4b46347c0abe5269c4f0e207b
Autor:
Bhavani Kashyap, Kathryn A Wyman‐Chick, Leah R Hanson, Samantha J Sherman, Aleta L Svitak, Lauren R O'Keefe, Ella A Chrenka, Michael Edward Sughrue, Michael H Rosenbloom
Publikováno v:
Alzheimer's & Dementia. 18
Autor:
Bhavani Kashyap, William H. Frey, Aleta L. Svitak, Michael H. Rosenbloom, Terry R. Barclay, Lauren R O'Keefe, Leah R. Hanson, Lyndsay M. Hage, Maria Pyle
Publikováno v:
Drugs & Aging. 38:407-415
Intranasal insulin is a potential treatment for neurodegenerative disease shown to increase cerebral glucose uptake, reduce amyloid plaques, and improve verbal memory in cognitively impaired as well as healthy adults. Investigations have suggested ra
Autor:
Justin Johnsen, Maria Pyle, Lauren O. Erickson, William H. Frey, Terry R. Barclay, Leah R. Hanson, Michael H. Rosenbloom, Aleta L. Svitak
Publikováno v:
Drugs in R&D, Vol 20, Iss 1, Pp 11-15 (2020)
Drugs in R&D
Drugs in R&D
Background Individuals with Down syndrome are likely to develop clinical and neuropathological brain changes resembling Alzheimer’s disease dementia by the ages of 35–40 years. Intranasal insulin is a potential treatment for neurodegenerative dis
Autor:
Gunda I. Georg, Usha Mishra, Davin Rautiola, Ronald A. Siegel, Narsihmulu Cheryala, Katherine A. Faltesek, Kathryn M. Nelson, Aleta L. Svitak, Lisa D. Coles, James C. Cloyd, Jared M. Fine, Leah R. Hanson, Patricia D. Maglalang
Publikováno v:
J Pharmacol Exp Ther
Intranasal administration is an attractive route for systemic delivery of small, lipophilic drugs because they are rapidly absorbed through the nasal mucosa into systemic circulation. However, the low solubility of lipophilic drugs often precludes aq
Autor:
Aleta L. Svitak, Terry R. Barclay, Lauren O. Erickson, Emily A. Green, William H. Frey, Lyndsay M. Hage, Leah R. Hanson, Michael H. Rosenbloom, Maria Pyle
Publikováno v:
Alzheimer's & Dementia. 16
Autor:
Katherine A. Faltesek, Jacob Kosyakovsky, Jared M. Fine, Aleta L. Svitak, Leah R. Hanson, Jacob M. Cooner, Amanda M. Baillargeon, William H. Frey, Julian Tokarev
Publikováno v:
Brain and Behavior
Brain and Behavior, Vol 10, Iss 3, Pp n/a-n/a (2020)
Brain and Behavior, Vol 10, Iss 3, Pp n/a-n/a (2020)
Introduction Intranasal deferoxamine (IN DFO) has been shown to decrease memory loss and have beneficial impacts across several models of neurologic disease and injury, including rodent models of Alzheimer's and Parkinson's disease. Methods In order
Autor:
Aleta L. Svitak, Leah R. Hanson, Bruce A. Witthuhn, Jared M. Fine, William H. Frey, Jacob Kosyakovsky
Publikováno v:
ACS chemical neuroscience. 10(11)
Deferoxamine, a metal chelator, has been shown to be neuroprotective in animal models of ischemic stroke, traumatic brain injury and both subarachnoid and intracerebral hemorrhage. Intranasal deferoxamine (IN DFO) has also shown promise as a potentia
Autor:
Jared M. Fine, Deborah Bingham, Leah R. Hanson, William H. Frey, Aleta L. Svitak, Shyeilla V. Dhuria, S. Scott Panter, Amanda M. Baillargeon, Rachel B. Burns, Abdul N. Kazi
Publikováno v:
Neuroscience Letters. 627:155-159
Hypocretin-1 (HC, orexin-A) is a neuropeptide involved in regulating physiological functions of sleep, appetite and arousal, and it has been shown that intranasal (IN) administration can target HC to the brain. Recent clinical studies have shown that
Autor:
Aleta L. Svitak, Michael H. Rosenbloom, Justin Johnsen, Maria Pyle, Leah R. Hanson, Lauren O. Erickson, Terry R. Barclay, William H. Frey
Publikováno v:
Alzheimer's & Dementia. 15:P928-P929